Evidence map›Paper›PMID 41889418›Full record

ArticleFrontiers in oncology2026

Novel use of peak optimized particle therapy for the delivery of three-dimensional spatially fractionated radiotherapy.

James W Snider, Pouya Sabouri, Sina Mossahebi, Arpit M Chhabra, Jason K Molitoris, Tejan Diwanji, Katja M Langen, William F Regine, Mingyao Zhu, Charles B Simone

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

James W SniderPartners in Healthcare Technology, LLC, Alpharetta, GA, United States.
Pouya SabouriDepartment of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Sina MossahebiDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.
Arpit M ChhabraNew York Proton Center, New York, NY, United States.
Jason K MolitorisDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.
Tejan DiwanjiDepartment of Radiation Oncology, Mid-Atlantic Permanente Medical Group PC, Rockville, MD, United States.
Katja M LangenDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, United States.
William F RegineDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.
Mingyao ZhuDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, United States.
Charles B SimoneNew York Proton Center, New York, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spatially fractionated radiotherapy (SFRT) has been delivered safely and effectively mostly utilizing beamlets of megavoltage photons in recent years. Particle therapy offers the promise of improved dose distributions with less exposure of surrounding normal tissues. However, most efforts have focused on mimicking the beamlets of traditional SFRT two-dimensional therapy (also known as GRID), potentially sacrificing advantages that could be achieved with scanned particle beams. We, herein, lay out the rationale for and execution of a novel pencil beam scanning proton therapy technique for SFRT that prioritizes pristine Bragg peak delivery in an interleaved and rotated three-dimensional SFRT (LATTICE) format. We propose that this patented (US11478665B2) technique optimizes particle SFRT therapy radiobiologic effect, minimizes normal tissue and superficial dose, and allows for alternative SFRT applications across a course of therapy. This technique lends itself to further exploration in delivery techniques, fractionation, and ultra-high dose rates.

Indexed as

FLASH radiotherapylatticeparticle therapyproton therapyspatially fractionated radiotherapy

Identifiers

PMID41889418
PMCPMC13013014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.